A carregar...

Denosumab and Changes in Bone Turnover Markers During Androgen Deprivation Therapy for Prostate Cancer

Androgen deprivation therapy (ADT) for prostate cancer increases fracture risk, decreases bone mineral density, and increases bone turnover markers (BTMs) including serum type 1 C-telopeptide (sCTX), tartrate-resistant alkaline phosphatase 5b (TRAP-5b), and procollagen-1 N-terminal telopeptide (P1NP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smith, Matthew R, Saad, Fred, Egerdie, Blair, Sieber, Paul, Tammela, Teuvo LJ, Leder, Benjamin Z, Ke, Chunlei, Goessl, Carsten
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3222788/
https://ncbi.nlm.nih.gov/pubmed/21898590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.492
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!